Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BMP Sunstone bids for Shengda

This article was originally published in The Tan Sheet

Executive Summary

BMP Sunstone, a U.S. firm operating in China, signed a non-binding letter of intent to purchase 75 percent of Chinese firm Zhangjiakou Shengda Pharmaceutical Co. for approximately $4.4 million, the firm says in a July 18 release. BMP Sunstone says the terms of the acquisition have not been finalized, but the firm expects to complete the acquisition by the end of the fourth quarter of 2008. The terms also includes a six-month exclusivity clause. The Plymouth Meeting, Pa.-based firm says Shengda's products will help expand and strengthen its Good Baby product line. "They fit nicely under our Good Baby brand and also complement our pediatrics franchise in both the OTC and Rx markets," BMP Sunstone President and COO Zhiqiang Han says in the release...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS101910

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel